Director/PDMR Shareholding

Summary by AI BETAClose X

Catherine Emma Newlands, a person closely associated with a director of CQS New City High Yield Fund Limited, purchased 40,000 ordinary shares of no par value on 23 July 2026 at a price of £0.52244 per share on the London Stock Exchange. This transaction, representing an aggregate volume of 40,000 shares at £0.52244 each, is an initial notification under the UK Market Abuse Regulation.

Disclaimer*

CQS New City High Yield Fund Ltd
27 July 2026
 

 27 July 2026

CQS New City High Yield Fund Limited

(the Company)

 

Notification of Transactions by Directors and

Persons Discharging Managerial Responsibilities

 

The below notification is made in accordance with the requirements of Article 19(3) of the UK Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities / person closely associated

 

(a)

Name

 

Catherine Emma Newlands

2

Reason for the notification

 

(a)

Position/status

 

PCA to director of the Company

(b)

Initial notification/Amendment

 

Initial notification

3

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer

(a)

Name

 

CQS New City High Yield Fund Limited

(b)

LEI

 

549300KMGN75B0PTWT07

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of financial instrument, type of instrument

 

Identification code

 

Ordinary Shares of no par value

 

 

ISIN : JE00B1LZS514

 

(b)

Nature of the transaction

 

Purchase of Ordinary Shares

(c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

£0.52244

40,000

(d)

Aggregate information

·      Aggregated volume

 

·      Price

 

40,000

£0.52244 per share

(e)

Date of transaction

 

23 July 2026

(f)

Place of transaction

London Stock Exchange (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings